Skip to content
MarketScale
‹ Back to IndustriesHealthcare

At HIMSS 2023, Companies Tackle Physician Burnout With Voice-Based AI

In a time when healthcare professionals confront unparalleled obstacles, a pertinent question in the realm of healthcare is how can doctors be supported in preserving their well-being and efficiency. HIMSS 2023  unveiled cutting-edge healthcare solutions, targeting AI technology and the crucial issue of physician burnout during the COVID-19 pandemic—breakthroughs that could potentially transform the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In a time when healthcare professionals confront unparalleled obstacles, a pertinent question in the realm of healthcare is how can doctors be supported in preserving their well-being and efficiency. HIMSS 2023 unveiled cutting-edge healthcare solutions, targeting AI technology and the crucial issue of physician burnout during the COVID-19 pandemic—breakthroughs that could potentially transform the healthcare landscape.

HIMSS, in a nutshell, is an event that unites healthcare professionals, innovators, and market suppliers globally to discuss the latest advancements in healthcare technology. With over 1,000 companies attending, topics such as digital health transformation, AI, telehealth, and cybersecurity are explored. In addition, physician burnout, which has been exacerbated drastically by the pandemic, is one of the more critical concerns addressed. In fact, a recent study reveals that burnout rates among US physicians have skyrocketed, with one in five considering leaving their current practice within two years due to stress. HIMSS 2023 aimed to tackle this crisis by featuring Suki, a voice-based digital assistant for doctors. Suki aims to alleviate clinician burnout, allowing doctors to focus on patient care while improving efficiency and cost savings. 

Punit Soni, CEO of Suki, shares how Suki is making healthcare tech-assisted and invisible, enabling doctors to work more efficiently and reduce clinician burnout.

Punit’s Thoughts:

“Great. Well, we are Suki, and we are a voice-based digital assistant for doctors. The biggest public health crisis in the country that very few people talk about is clinician burnout. And what Suki does is actually help doctors to basically focus on clinical care and makes healthcare tech-assisted when invisible so that they can do that.

That’s why we are here, and we are trying to make sure that doctors can find out about us. In today’s world where large language models and all sorts of AI technology is the absolute buzzword, we’ve been doing this for about five or six years.

And the key things about Suki is you can use Suki to dictate, you can use Suki to command and get information about the patient if you want to. You can also use Suki and put it in ‘ambient mode’ so that it can automatically generate notes out of a patient-doctor conversation. And if you like pure software that can actually help you do all of those things and works well with your EHRs, then Suki is the right place to be.”

Article written by: Azam Saghir

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512